Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Oncothyreon shares hit annual high on long-term data from study of Stimuvax in lung cancer
Oncothyreon shares hit annual high on long-term data from study of Stimuvax in lung cancer
Oncothyreon shares hit annual high on long-term data from study of Stimuvax in lung cancer
Submitted by
admin
on August 4, 2009 - 8:35am
Source:
Yahoo/AP
News Tags:
Oncothyreon
Stimuvax
lung cancer
Headline:
Oncothyreon shares hit annual high on long-term data from study of Stimuvax in lung cancer
Do Not Allow Advertisers to Use My Personal information
